Beckley Psytech Archives -

Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with

Consolidation in psychedelics starts as Beckley and Eleusis combine

https://pharmaphorum.com/news/consolidation-in-psychedelics-starts-as-beckley-and-eleusis-combine/

Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring,

Beckley adds digital element to its psychedelic drug trials

https://pharmaphorum.com/news/beckley-adds-digital-element-to-its-psychedelic-drug-trials/

Psychedelic medicines specialist Beckley Psytech has enticed a senior figure in Janssen’s neuroscience division to take on the

Psychedelics startup Beckley attracts Janssen neuroscience VP

https://pharmaphorum.com/news/psychedelics-startup-beckley-attracts-janssen-neuroscience-vp/

The first patient has received a low dose of Beckley Psytech’s psychedelic medicine psilocybin in a clinical trial

First subject dosed in psilocybin trial for rare headache disorder

https://pharmaphorum.com/news/first-subject-dosed-in-psilocybin-trial-for-rare-headache-disorder/

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed

Beckley Psytech raises $80m for psychedelic meds development

https://pharmaphorum.com/news/beckley-psytech-raises-80m-for-psychedelic-meds-development/

Beckley Psytech